50-168-5222

CD68 Mouse anti-Human, Clone: UMAB150, liquid, UltraMAB™

Manufacturer: OriGene

Select a Size

Pack Size SKU Availability Price
Each of 1 50-168-5222-Each-of-1 In Stock ₹ 56,721.48

50-168-5222 - Each of 1

₹ 56,721.48

In Stock

Quantity

1

Base Price: ₹ 56,721.48

GST (18%): ₹ 10,209.866

Total Price: ₹ 66,931.346

Antigen

CD68

Classification

Monoclonal

Concentration

0.5-1.0 mg/mL

Formulation

PBS with 1% BSA, 50% glycerol and 0.02% sodium azide

Gene Accession No.

P34810

Gene Symbols

CD68

Immunogen

Human recombit protein fragment corresponding to amino acids 22-319 of human CD68 produced in SF9 cell.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1

Applications

Immunohistochemistry (Paraffin), Western Blot

Clone

UMAB150

Conjugate

Unconjugated

Gene

CD68

Gene Alias

GP110, LAMP4, SCARD1

Host Species

Mouse

Purification Method

Affinity Chromatography

Regulatory Status

RUO

Gene ID (Entrez)

968

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Related Products

Img

OriGene

50-168-5223

--

Img

OriGene

50-166-6255

--

Img

OriGene

50-166-6257

--

Img

OriGene

50-168-1879

--

Img

OriGene

50-168-1897

--

Img

OriGene

50-168-1864

--

Img

OriGene

50-168-2445

--

Img

OriGene

50-168-2423

--

Description

  • CD68 (Macrosialin) is a 110 kDa integral membrane glycoprotein predomitly expressed on the intracellular lysomsomes of monocytes and macrophages and to a lesser extent by dendritic cells and peripheral blood granulocytes
  • Also, CD68 could play a role in phagocytic activities of tissue macrophages, both in intracellular lysosomal metabolism and extracellular cell-cell and cell-pathogen interactions
  • CD68 is expressed by interdigitating reticulum cells in tonsil and some histiocytic lymphoma or histiocytosis, acute myeloid leukemia (AML), and granulocytic sarcoma
  • Elevated expression of CD68 has been demonstrated on CD34+ cells in various human maligcies, including several Acute Myeloid Leukemia studies.